“Daily Practice Use of Bortezomib in Relapsed Refractory Multiple Myeloma: Safety Efficacy Results of a Compassionate Use Program in Switzerland”. Swiss Medical Weekly, vol. 137, no. 2122, June 2007, pp. 317-22, https://doi.org/10.4414/smw.2007.11716.